Global Assets Advisory LLC Buys Shares of 18,900 Koninklijke Philips N.V. (NYSE:PHG)

Global Assets Advisory LLC purchased a new position in Koninklijke Philips N.V. (NYSE:PHG - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 18,900 shares of the technology company's stock, valued at approximately $445,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in PHG. Sei Investments Co. grew its stake in shares of Koninklijke Philips by 5.2% in the fourth quarter. Sei Investments Co. now owns 308,673 shares of the technology company's stock worth $7,816,000 after acquiring an additional 15,395 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its stake in shares of Koninklijke Philips by 107.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 129,624 shares of the technology company's stock worth $3,282,000 after acquiring an additional 67,289 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Koninklijke Philips in the fourth quarter worth $10,655,000. QRG Capital Management Inc. grew its stake in shares of Koninklijke Philips by 11.0% in the first quarter. QRG Capital Management Inc. now owns 142,595 shares of the technology company's stock worth $3,622,000 after acquiring an additional 14,090 shares during the last quarter. Finally, American Century Companies Inc. grew its stake in shares of Koninklijke Philips by 23.4% in the fourth quarter. American Century Companies Inc. now owns 295,158 shares of the technology company's stock worth $7,473,000 after acquiring an additional 55,911 shares during the last quarter. 13.67% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. Wall Street Zen cut Koninklijke Philips from a "buy" rating to a "hold" rating in a research note on Sunday, June 15th. Sanford C. Bernstein raised Koninklijke Philips from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, March 18th. Two investment analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy".

Koninklijke Philips Stock Performance

Shares of NYSE:PHG traded up $0.06 during midday trading on Friday, reaching $24.14. 758,921 shares of the company's stock traded hands, compared to its average volume of 897,432. The company has a market cap of $23.24 billion, a price-to-earnings ratio of 56.14, a P/E/G ratio of 0.68 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.79 and a current ratio of 1.28. Koninklijke Philips N.V. has a one year low of $20.61 and a one year high of $31.57. The stock has a 50 day moving average of $23.72 and a 200 day moving average of $25.04.

Koninklijke Philips (NYSE:PHG - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The technology company reported $0.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.14 by $0.13. The firm had revenue of $4.31 billion for the quarter, compared to the consensus estimate of $4.10 billion. Koninklijke Philips had a return on equity of 10.97% and a net margin of 2.11%. The company's quarterly revenue was down 1.0% on a year-over-year basis. During the same period in the prior year, the company posted $0.21 earnings per share. As a group, equities research analysts anticipate that Koninklijke Philips N.V. will post 1.63 EPS for the current fiscal year.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.